» Articles » PMID: 30306593

Role of Imaging in the Routine Management of Endometrial Cancer

Overview
Publisher Wiley
Date 2018 Oct 12
PMID 30306593
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Endometrial cancer is the most common gynecologic cancer in women today. It is surgically staged, and while surgery is the primary treatment modality, the identification of disease extent-in particular extrauterine spread-prior to surgery is important to optimize treatment decision making. Ultrasound and MRI are useful for evaluating the extent of local disease, while CT and PET are used for detecting lymph node or distant metastases. Diffusion-weighted MRI has also been used for detecting small metastatic deposits in lymph nodes and omentum. Extrauterine soft tissue involvement can be detected by ultrasound, CT, MRI, and PET. Recently, intraoperative visualization techniques, such as sentinel lymph node mapping, are increasingly used to avoid extensive surgical staging without compromising treatment. Imaging is also used for planning adjuvant treatment and detection of postoperative residual disease in high-risk patients, monitoring and detecting recurrent disease, and in post-treatment surveillance of asymptomatic patients with high risk of relapse.

Citing Articles

Management of Endometrial Cancer: A Comparative Review of Guidelines.

Kopatsaris S, Tsakiridis I, Kapetanios G, Zachomitros F, Michos G, Papanikolaou E Cancers (Basel). 2024; 16(21).

PMID: 39518023 PMC: 11545286. DOI: 10.3390/cancers16213582.


Role of Multiparametric MRI in the Preoperative Evaluation of Endometrial Carcinoma: A Cross-Sectional Study.

Pati S, Mondal K, Bodhey N, Bagde N, Gupta R, Shukla A Cureus. 2024; 16(7):e65058.

PMID: 39171058 PMC: 11335962. DOI: 10.7759/cureus.65058.


Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy.

Bostan I, Mihaila M, Roman V, Radu N, Neagu M, Bostan M Cancers (Basel). 2024; 16(11).

PMID: 38893147 PMC: 11171255. DOI: 10.3390/cancers16112027.


Preliminary Experience with Virtual Monoenergetic Imaging and Iodine Mapping in the Primary Staging of Endometrial Cancer.

Sauer S, Huflage H, Christner S, Patzer T, Kiesel M, Quenzer A Cancers (Basel). 2024; 16(6).

PMID: 38539562 PMC: 10968725. DOI: 10.3390/cancers16061229.


Performance of MRI for Detection of ≥pT1b Disease in Local Staging of Endometrial Cancer.

Van Vynckt L, Tummers P, Denys H, Goker M, Hendrickx S, Naert E Cancers (Basel). 2024; 16(6).

PMID: 38539477 PMC: 10968934. DOI: 10.3390/cancers16061142.


References
1.
Mariani A, Webb M, Keeney G, Haddock M, Calori G, Podratz K . Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?. Am J Obstet Gynecol. 2000; 182(6):1506-19. DOI: 10.1067/mob.2000.107335. View

2.
Dijkhuizen F, Mol B, Brolmann H, Heintz A . The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000; 89(8):1765-72. View

3.
Narayan K, Hicks R, Jobling T, Bernshaw D, McKenzie A . A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer. 2001; 11(4):263-71. DOI: 10.1046/j.1525-1438.2001.011004263.x. View

4.
Belhocine T, De Barsy C, Hustinx R . Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging. 2002; 29(9):1132-9. DOI: 10.1007/s00259-002-0878-2. View

5.
Chung H, Kang S, Cho J, Kim J, Park N, Song Y . Accuracy of MR imaging for the prediction of myometrial invasion of endometrial carcinoma. Gynecol Oncol. 2006; 104(3):654-9. DOI: 10.1016/j.ygyno.2006.10.007. View